We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Eyes Down For Reckitt Benckiser Group Plc’s Results

We’ll see how Reckitt Benckiser Group Plc (LON: RB) fared in 2013.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Reckitt Benckiser Group (LSE: RB) (NASDAQOTH: RBGLY.US) shares have had a mixed ride — they’re up around 11% over 12 months to 4,656p, against a 3% rise for the FTSE 100, but it’s been a bit volatile.

The company was seen as something of a safe haven back in recession time, and its earnings were going strong — in 2009, we saw a 24% rise in earnings per share (EPS). But that growth has been slowing, down to just 7% by 2012. And analysts are actually expecting a modest fall of 1% for the year just ended in December 2013, with the same penciled in for 2014.

Should you buy Reckitt Benckiser Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Results next week

Whether they’re right is something we shall find out on Wednesday 12 February, when we’ll have those 2013 results. But how has the year been going so far?

In third-quarter results released in October 2013, the owner of an array worldwide consumer brands reported like-for-like revenue growth of 5% for the quarter and the same for the year-to-date, excluding its pharmaceuticals business (RBP). Chief executive Rakesh Kapoor told us that the firm’s focus on health and hygiene and emerging markets was “delivering good results“.

And of RBP, he said “…we are commencing a strategic review of the business and will consider all options for maximising value for our shareholders. We expect the review to take some time and will update shareholders during the course of 2014“.

Prospects?

What of the full-year? Well, Mr Kapoor used that nasty “challenging” word when describing market conditions, but predicted full-year revenue growth of at least 6% with margins expected to be maintained.

Looking back further, statutory first-half EPS reported in July 2013 dropped 14% to 90.4p, though the company claimed a 7% rise to 118.3p for adjusted EPS. Like-for-like revenue at the time was up 6%, excluding RBP, with adjusted operating profit up 2% (though statutory operating profit fell 17%).

Looking at the spread of analysts’ opinions in the light of the year so far, I think Reckitt Benckiser’s 2013 EPS could be anywhere in a range of a few percent down to a few percent up.

Dividends

But what about dividends? Reckitt Benckiser traditionally provides a fairly average annual yield of a little over 3%, though it did rise a bit above that in the past couple of years as the share price fell back a little.

There’s a modest 3% rise in the 2013 dividend expected, to take it to about 138p per share for a yield of 3%. But the first-half dividend was lifted by 7% to 60p per share, so if anything that could be a bit conservative — in fact, the most recent forecasts are suggesting around 140p per share.

> Alan does not own any shares in Reckitt Benckiser.

More on Investing Articles

Curtains, happy woman and thinking of future in home, planning and reflection of mindset with view. Window, smile and African girl with vision, ideas and dream for morning inspiration in living room.
Investing Articles

Up 50% in a year! That’s not the only reason I’d consider buying Barclays over Nvidia stock today

Harvey Jones says that Nvidia stock is probably one of the safer ways to play the artificial intelligence revolution. But…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

Here’s why I bought this 7.6%-yielding FTSE 100 dividend stock instead of saving in a Cash ISA

Harvey Jones crunches the numbers to show how investing in stocks and shares can be much more profitable than saving…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Here’s how much passive income 1,000 Greggs shares could pay…

Greggs shares have lost nearly 50% of their value inside the past two years. Is this out-of-favour passive income stock…

Read more »

Overjoyed exited middle aged married couple giving high five, finishing doing domestic paperwork together at home. Euphoric happy older mature spouses celebrating successful investment or purchase.
Investing Articles

This beaten-down FTSE 100 dividend share just jumped 11% in a week but still yields almost 5%

Harvey Jones has been highlighting this dividend share opportunity for weeks and suddenly it's showing signs of life. Can the…

Read more »

Investing Articles

Down 53% since May, is this SpaceX-backed UK stock now in the bargain bin?

The Filtronic (LSE:FTC) share price has come crashing back down to earth in recent weeks. Has the selling gone too…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

3,566 shares in this FTSE 100 stalwart earns a £1,443 second income

Stephen Wright sees Unilever's battered share price as an attractive option for investors looking for a second income to consider.

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

3 stocks I’m looking to buy in July

Stephen Wright’s stocks to buy list for July includes a specialist chemicals recovery play, a quiet infrastructure compounder, and an…

Read more »

ISA Individual Savings Account
Investing Articles

How do the government’s latest changes affect your Stocks and Shares ISA?

Stephen Wright explains what the new anti-circumvention rules mean for investors with uninvested cash in their Stocks and Shares ISAs.

Read more »